| Cat. No. |
Product Name |
Information |
| PC-42380 |
VUF10460
Histamine H4 agonist
|
VUF10460 is a potent, selective histamine H4 receptor agonist with pKi of 7.46 and 8.22 for rat and human H4, respectively. |
| PC-45369 |
Decloxizine
Histamin H1 antagonist
|
Decloxizine (UCB-1402, NSC-289116) is a potent histamine 1 (H1) receptor antagonist. |
| PC-42908 |
ABT-239
Histamine H3 antagonist
|
ABT-239 is a potent and selective Histamine H3 receptor antagonist with Ki of 0.1-5.8 nM (human, rat H3). |
| PC-42911 |
Pitolisant hydrochloride
H3 receptor antagonist
|
Pitolisant hydrochloride (Ciproxidine, BF2649) is a potent and selective antagonist of H3 receptor with Ki/EC50 of 0.16/1.5 nM. |
| PC-42909 |
Pitolisant
H3 receptor antagonist
|
Pitolisant (Tiprolisant, BF-2649, BF 2.649) is a potent and selective antagonist of H3 receptor with Ki/EC50 of 0.16/1.5 nM. |
| PC-45163 |
Alcaftadine
Histamine H1 antagonist
|
Alcaftadine (R-89674) is a H1 histamine receptor antagonist that used for prevention of allergic conjunctivitis, has a high affinity for histamine H1 and H2 receptors and a lower affinity for H4 receptors. |
| PC-45251 |
Tripelennamine hydrochloride
H1 receptor antagonist
|
Tripelennamine hydrochloride (Pyribenzamine hydrochloride) is the first-generation antihistamine that acts primarily as H1 receptor antagonist. |
| PC-27477 |
GSK189254
H3R antagonist
|
GSK189254 (GSK189254A hydrochloride) is a potent, selective histamine H3 receptor (H3R) antagonist with pKi of 9.59 -9.90 and 8.51-9.17 for human and rat H3R respectively. |
| PC-27476 |
GSK189254A
H3R antagonist
|
GSK189254A (GSK189254 free base) is a potent, selective histamine H3 receptor (H3R) antagonist with pKi of 9.59 -9.90 and 8.51-9.17 for human and rat H3R respectively. |
| PC-27475 |
GSK207040
H3R antagonist
|
GSK207040 is a potent, selective histamine H3 receptor (H3R) antagonist with pKi of 9.67 and 9.08 for human and rat H3 receptors respectively. |
| PC-27473 |
GSK334429
H3R antagonist
|
GSK334429 is a potent, selective histamine H3 receptor (H3R) antagonist with pKi of 9.49 and 9.12 for human and rat H3 receptors respectively. |
| PC-26776 |
Fexofenadine
H1 receptor antagonist, ADAM17 inhibitor
|
Fexofenadine (MDL-16455) is an orally active and nonsedative H1 receptor antagonist, also binds and inhibits the catalytic activity of human ADAM17, shows anti-inflammatory effects. |
